Aardvark Therapeutics

Aardvark Therapeutics is a clinical-stage biopharmaceutical company led by CEO Tien Lee, M.D., focused on developing and commercializing novel small-molecule therapies to activate innate homeostatic pathways for the treatment of obesity and rare genetic metabolic disorders.